NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of UnitedHealth Group Inc. (NYSE: UNH) between March 14, 2022 and February 27, 2024, both dates inclusive (the “Class Period”), of the important July 15, 2024 lead plaintiff deadline. SO WHAT: If you purchased UnitedHealth common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arr ...

NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Malibu Boats, Inc. (NASDAQ: MBUU) between November 4, 2022 and April 11, 2024, both dates inclusive (the “Class Period”), of the important June 28, 2024 lead plaintiff deadline. SO WHAT: If you purchased Malibu Boats securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangemen ...

NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Equinix, Inc. (NASDAQ: EQIX) between May 3, 2019 and March 24, 2024, both dates inclusive (the “Class Period”), of the important July 1, 2024 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Equinix securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or ...

NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between December 1, 2023 and April 26, 2024, both dates inclusive (the “Class Period”), of the important July 5, 2024 lead plaintiff deadline. SO WHAT: If you purchased Altimmune securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT ...

NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of FutureFuel Corp. (NYSE: FF) resulting from allegations that FutureFuel may have issued materially misleading business information to the investing public. SO WHAT: If you purchased FutureFuel securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangem ...

NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Globe Life Inc. f/k/a Torchmark Corporation (NYSE: GL) between May 8, 2019 and April 10, 2024, both dates inclusive (the “Class Period”), of the important July 1, 2024 lead plaintiff deadline. SO WHAT: If you purchased Globe Life common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingen ...

NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Exscientia p.l.c (NASDAQ: EXAI) between March 23, 2022 and February 12, 2024, both dates inclusive (the “Class Period”), of the important June 25, 2024 lead plaintiff deadline. SO WHAT: If you purchased Exscientia securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...

NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) between June 4, 2019 and May 3, 2022, both dates inclusive (the “Class Period”), of the important June 24, 2024 lead plaintiff deadline. SO WHAT: If you purchased Global Cord securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fe ...

文章核心观点 - 玛瑞纳斯制药公司(Marinus Pharmaceuticals, Inc.)证券在2021年3月17日至2024年5月7日期间的投资者遭受损失,原因是公司在该期间做出了虚假或误导性陈述 [1][6] - 原告律师事务所罗森法律事务所(Rosen Law Firm)代表投资者提起集体诉讼,要求获得赔偿 [1][2][3][7] 根据相关目录分别进行总结 案件背景 - 玛瑞纳斯制药公司证券在2021年3月17日至2024年5月7日期间的投资者遭受损失 [1][6] - 罗森法律事务所代表投资者提起集体诉讼 [1][2][3][7] 案件进展 - 投资者可以通过https://rosenlegal.com/submit-form/?case_id=25735或联系律师Phillip Kim参与集体诉讼 [3][7] - 在2024年8月5日之前,投资者可以申请担任首席原告 [3][7] - 罗森法律事务所在证券集体诉讼方面拥有丰富经验,曾获得多项殊荣 [4][5][10]

NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Perion Network Ltd. (NASDAQ: PERI) between February 9, 2021 and April 5, 2024, both dates inclusive (the “Class Period”), of the important June 17, 2024 lead plaintiff deadline. SO WHAT: If you purchased Perion common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...